 Erika Lasda
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trans-Splicing | 4 | 2011 | 12 | 1.130 |
Why?
| | RNA | 5 | 2024 | 877 | 0.820 |
Why?
| | RNA, Spliced Leader | 4 | 2011 | 12 | 0.810 |
Why?
| | Caenorhabditis elegans | 3 | 2011 | 296 | 0.600 |
Why?
| | Viroids | 1 | 2014 | 2 | 0.470 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 68 | 0.470 |
Why?
| | Exosomes | 1 | 2016 | 97 | 0.460 |
Why?
| | RNA Precursors | 3 | 2011 | 148 | 0.440 |
Why?
| | RNA Splicing | 2 | 2014 | 259 | 0.420 |
Why?
| | Ribonucleoproteins, Small Nuclear | 2 | 2010 | 22 | 0.410 |
Why?
| | Alternative Splicing | 6 | 2008 | 216 | 0.380 |
Why?
| | Virus Replication | 1 | 2014 | 453 | 0.380 |
Why?
| | Cell Extracts | 1 | 2011 | 17 | 0.360 |
Why?
| | Carrier State | 2 | 2021 | 60 | 0.350 |
Why?
| | RNA-Binding Proteins | 3 | 2024 | 388 | 0.260 |
Why?
| | RNA, Long Noncoding | 2 | 2024 | 177 | 0.240 |
Why?
| | Asymptomatic Infections | 2 | 2021 | 26 | 0.230 |
Why?
| | Therapeutics | 1 | 2004 | 14 | 0.220 |
Why?
| | Nucleic Acid Conformation | 4 | 2024 | 706 | 0.210 |
Why?
| | Viral Load | 2 | 2021 | 449 | 0.200 |
Why?
| | Saliva | 2 | 2021 | 212 | 0.200 |
Why?
| | Base Sequence | 5 | 2011 | 2142 | 0.190 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 615 | 0.160 |
Why?
| | Holoenzymes | 1 | 2018 | 22 | 0.150 |
Why?
| | Transcription, Genetic | 1 | 2024 | 1416 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 855 | 0.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2018 | 185 | 0.140 |
Why?
| | Cell Line | 3 | 2024 | 2780 | 0.130 |
Why?
| | Chemical Precipitation | 1 | 2016 | 37 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 1 | 2004 | 2271 | 0.120 |
Why?
| | Introns | 2 | 2014 | 249 | 0.120 |
Why?
| | Cytoplasm | 1 | 2016 | 269 | 0.120 |
Why?
| | RNA Splice Sites | 1 | 2014 | 44 | 0.120 |
Why?
| | Exons | 3 | 2018 | 341 | 0.110 |
Why?
| | Operon | 2 | 2011 | 64 | 0.100 |
Why?
| | Evolution, Molecular | 2 | 2011 | 462 | 0.100 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2003 | 65 | 0.100 |
Why?
| | Molecular Sequence Data | 4 | 2011 | 2833 | 0.100 |
Why?
| | Animals | 11 | 2023 | 35409 | 0.100 |
Why?
| | Spliceosomes | 1 | 2011 | 46 | 0.090 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2008 | 24 | 0.090 |
Why?
| | Inverted Repeat Sequences | 1 | 2010 | 19 | 0.090 |
Why?
| | Consensus Sequence | 1 | 2010 | 72 | 0.090 |
Why?
| | Uridine | 1 | 2010 | 29 | 0.090 |
Why?
| | RNA Stability | 1 | 2011 | 103 | 0.080 |
Why?
| | RNA, Viral | 2 | 2024 | 620 | 0.080 |
Why?
| | Universities | 2 | 2021 | 409 | 0.080 |
Why?
| | MicroRNAs | 1 | 2014 | 680 | 0.070 |
Why?
| | Phylogeny | 1 | 2011 | 845 | 0.070 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 2 | 2008 | 13 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 177 | 0.070 |
Why?
| | Sodium Channels | 1 | 2006 | 66 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 182 | 0.060 |
Why?
| | Computational Biology | 1 | 2010 | 594 | 0.060 |
Why?
| | Brain | 1 | 2018 | 2677 | 0.060 |
Why?
| | Actin Cytoskeleton | 1 | 2006 | 102 | 0.060 |
Why?
| | Humans | 11 | 2024 | 129847 | 0.060 |
Why?
| | CCCTC-Binding Factor | 1 | 2024 | 14 | 0.060 |
Why?
| | Levivirus | 1 | 2024 | 18 | 0.060 |
Why?
| | Actins | 1 | 2006 | 410 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2024 | 156 | 0.050 |
Why?
| | Protein Binding | 3 | 2024 | 2123 | 0.050 |
Why?
| | Models, Biological | 1 | 2011 | 1724 | 0.050 |
Why?
| | Rats | 5 | 2018 | 5487 | 0.050 |
Why?
| | Zebrafish Proteins | 1 | 2006 | 268 | 0.050 |
Why?
| | Pandemics | 2 | 2021 | 1500 | 0.050 |
Why?
| | Listeria monocytogenes | 1 | 2023 | 123 | 0.050 |
Why?
| | Zebrafish | 1 | 2006 | 460 | 0.050 |
Why?
| | Telomerase | 1 | 2024 | 231 | 0.050 |
Why?
| | Protein Transport | 2 | 2018 | 429 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2002 | 62 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2003 | 231 | 0.050 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 32 | 0.040 |
Why?
| | Immunologic Memory | 1 | 2023 | 349 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2002 | 207 | 0.040 |
Why?
| | Binding Sites | 1 | 2024 | 1251 | 0.040 |
Why?
| | Protein Isoforms | 2 | 2018 | 393 | 0.040 |
Why?
| | Virion | 1 | 2021 | 84 | 0.040 |
Why?
| | Models, Statistical | 1 | 2024 | 624 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 98 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 163 | 0.040 |
Why?
| | Mice | 4 | 2023 | 16983 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2024 | 2545 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 284 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 254 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1847 | 0.030 |
Why?
| | Students | 1 | 2021 | 582 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2018 | 2703 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2023 | 1900 | 0.030 |
Why?
| | Phenotype | 1 | 2004 | 3062 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1645 | 0.030 |
Why?
| | Mesoderm | 2 | 2008 | 138 | 0.030 |
Why?
| | Time Factors | 1 | 2024 | 6550 | 0.030 |
Why?
| | Mass Screening | 1 | 2021 | 1192 | 0.030 |
Why?
| | Mutation | 1 | 2024 | 3706 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2023 | 5468 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2007 | 2057 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2079 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2006 | 820 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4410 | 0.020 |
Why?
| | Globins | 1 | 2008 | 21 | 0.020 |
Why?
| | Organ Specificity | 1 | 2008 | 295 | 0.020 |
Why?
| | RNA, Helminth | 1 | 2007 | 17 | 0.020 |
Why?
| | Genes, Helminth | 1 | 2007 | 26 | 0.020 |
Why?
| | Epithelium | 1 | 2008 | 311 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2006 | 100 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 371 | 0.020 |
Why?
| | COS Cells | 1 | 2006 | 186 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 611 | 0.020 |
Why?
| | Chickens | 1 | 2006 | 188 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2006 | 94 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2006 | 167 | 0.020 |
Why?
| | Isoenzymes | 1 | 2006 | 301 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 6423 | 0.020 |
Why?
| | Larva | 1 | 2006 | 215 | 0.020 |
Why?
| | Protein Subunits | 1 | 2006 | 233 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 12467 | 0.010 |
Why?
| | Sea Urchins | 1 | 2003 | 7 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2003 | 179 | 0.010 |
Why?
| | Plasmids | 1 | 2003 | 360 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2003 | 51 | 0.010 |
Why?
| | Hepatitis Delta Virus | 1 | 2002 | 7 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2002 | 98 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1716 | 0.010 |
Why?
| | Formaldehyde | 1 | 2002 | 59 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 918 | 0.010 |
Why?
| | Myocardium | 1 | 2006 | 983 | 0.010 |
Why?
| | Models, Genetic | 1 | 2003 | 592 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2006 | 2403 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2003 | 778 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 954 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1686 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2003 | 1063 | 0.010 |
Why?
| | Female | 1 | 2018 | 68829 | 0.010 |
Why?
|
|
Lasda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|